Global markets for biomakers to grow to $33.3 billion by 2015

In 2010, the total market for biomarkers is expected to be nearly $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Learn about the various types of biomarkers and get an analysis of global market trends with projections through 2015. This report provides a range of information including detailed product analyses within disease sub segments, technological issues, regulatory issues and company profiles...
Use this report to:

• Quantify and qualify the market for products and services in the biomarkers segment
• Evaluate the introduction of combination therapies in the biomarkers arena, an important market driver expected to contribute substantially to market growth through the 5-year forecast period
• Allocate resources and make effective decisions regarding emerging players, technologies, and markets in relation to specific disease segments
• Examine the industry structure with a special focus on how new products and technologies anticipated to be released during the forecast period will influence the current standard of care and change the competitive environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE

GLOBAL BIOMARKERS FORECAST BY AREA, THROUGH 2015

($ MILLIONS)

Source: BCC Research

Global markets for biomakers to grow to $33.3 billion by 2015

In 2010, the total market for biomarkers is expected to be nearly $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Learn about the various types of biomarkers and get an analysis of global market trends with projections through 2015. This report provides a range of information including detailed product analyses within disease sub segments, technological issues, regulatory issues and company profiles...

Use this report to:

• Quantify and qualify the market for products and services in the biomarkers segment
• Evaluate the introduction of combination therapies in the biomarkers arena, an important market driver expected to contribute substantially to market growth through the 5-year forecast period
• Allocate resources and make effective decisions regarding emerging players, technologies, and markets in relation to specific disease segments
• Examine the industry structure with a special focus on how new products and technologies anticipated to be released during the forecast period will influence the current standard of care and change the competitive environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL BIOMARKERS FORECAST BY AREA, THROUGH 2015
($ MILLIONS)

Source: BCC Research

Biomarkers to experience explosive growth among global emerging pharmaceutical technologies

The total global emerging technologies market is comprised of a variety of fast growing and independent segments like therapeutic vaccines; infectious disease treatments; biomarkers; next-generation cardiovascular therapies; leading ophthalmic treatments; CNS: next-generation mechanisms of action; and cancer trends: evolving therapies. Out of these, biomarkers will experience explosive growth, increasing from a current $13.5 billion to $33.3 billion in 2015, a 19.8% CAGR for the forecast period.

Learn about the emerging pharmaceutical technologies on a global basis. Get information on products within disease sub segments, overall industry trends and relevant company profiles...

Use this report to:

• Quantify and qualify emerging markets for therapeutic drug products by product, product category, and by company 
• Develop strategies for accessing emerging markets by specific disease segments and geography in order to allocate resources and make effective decisions  
• Evaluate leading and emerging competitors, including companies with novel products in development, how their specific product strategies are employed, and how these new products and technologies are influencing the current standard of care  
• Identify overall market trends, product opportunities, emerging geographies, M&A opportunities and guiding insights for sales growth.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL EMERGING TECHNOLOGIES FORECAST BY AREA, 2009-2015 ($ MILLIONS)

Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics

Global market for Epigenomic Products was $662 billion in 2008, which increased to $930.6 million 2009, it is projected to reach $6 billion in 2014 at a 5 year CAGR of 45.4%.

Learn major Epigenomics technologies impacting the market today and emerging opportunities in biomarkers, diagnostics and therapeutics through 2014...

Use this report to:


• Receive a comprehensive discussion of where the state of the art is in epigenomics technologies and the current and future commercial potential for these key market segments, along with a study of the current large-scale epigenome funding projects as well as the industry competitive and patent dynamics


• Determine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5 year period from 2009 through 2014; by the four main segments for epigenomics: research tools, diagnostics, therapeutics, and assays for cellular therapies


• See the major epigenomics technologies that are now, or likely to become commercialized within the next 5 years, and examine the products from these technologies, market segments of the products, and sales forecasts and trends for 2009 through 2014


• Understand the fundamental epigenomic technologies, the market driving forces, product types, main market applications, key companies, strategic alliances and acquisitions, future global market potential and product sales forecasts for the period of 2009 through 2014.


Click here for more detailed information.


To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.